Tuesday, 25 Feb 2020


Datesort ascending Type Title Save
26 Nov 2019 Social #ACR19 abst #2476 Retrospective 2000-18 cohort study on side effects of MTX &TNFi in PSA vs RA: more side effects reported in MTX-PSA (42-46%) compared to MTX-RA pts (26-30%) or PsA or RA pts initiating a TNFi (20-25% of RA and 22-27% of PsA) @DrPetryna https://t.co/Eo3zwDgJMr https://t.co/eaq1gfD1eX
26 Nov 2019 Social #ACR19 ABS# 1481 Corrona PsA/SpA Registy: real-world use of COMBINATION Apremilast + biologics happens mostly in pts who received prior biologic therapy & pts not able to achieve MDA. @DrPetryna https://t.co/7OdLBalnPZ
21 Nov 2019 News Psoriatic Arthritis at ACR 2019
20 Nov 2019 Social @uptoTate PLENARY: COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/mfTTMaCgWg #ACR19 Abst #2729 https://t.co/qaEi39JFPp
20 Nov 2019 Social @EBRheum RCT Tildrakizumab (IL23i) in Psoriatic Arthritis; Beats PLBO for ACR20 (NNT~4), ACR50 (NNT~4), and pt global (NNT~3 for 50% improvement) Very well tolerated (NNH>50, any adverse event). Exciting new tx! Need comparison RCT vs TNF/IL17i Abst#1821 https://t.co/b2yLF2YUSE https://t.co/2KW1Xo1lP9
20 Nov 2019 ACR Video Panel Presentation: Psoriatic Arthritis
20 Nov 2019 ACR Video New Treatments for Axial Spondyloarthritis: Dr. Antoni Chan
20 Nov 2019 ACR Video Comparison of Ixekizumab and Adalimumab in PsA: Dr. Olga Petryna
20 Nov 2019 ACR Video Ixekizimab Withdrawal in PSA: Dr. Eric Ruderman
20 Nov 2019 ACR Video Pearls for Evaluating PsA Patients: Dr. Guillermo Valenzuela
20 Nov 2019 ACR Video Tofacitinib as Monotherapy Following MTX Withdrawal in PsA: Dr. Eric Ruderman
18 Nov 2019 ACR Video Non-radiographic axSpA: Dr. Philip Robinson
18 Nov 2019 ACR Video Highlights of AS, Psoriatic Arthritis Studies: Dr. Lianne Gensler
18 Nov 2019 ACR Video Inflammatory Back Pain in axSpA: Dr. Rachel Tate
18 Nov 2019 ACR Video Psoriatic Arthritis and Guselkumab: Dr. Eric Ruderman
18 Nov 2019 News New Treatments in Axial SpA from #ACR2019
13 Nov 2019 Social #ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx
13 Nov 2019 Social RT @synovialjoints: Results from2 anti-IL-17 agents Secukinumab and Ixekizumab in non-radiographic axial Spondyloarthritis poster #L2 and a…
13 Nov 2019 Social RT @synovialjoints: The ASAS40 and all major secondary endpoints for Ixekizumab Q4W and Q2W were met at Wk 16 and Wk 52 with no unexpected…
13 Nov 2019 Social RT @synovialjoints: PREVENT trial of Secukinumabnr-axSpA. SEC 150 mg loading and no loading dose provided significant improvement in signs…